SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-002282
Filing Date
2019-02-28
Accepted
2019-02-28 16:30:28
Documents
3
Period of Report
2019-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q418earningsrelease.htm 8-K 35997
2 EXHIBIT 99.1 exhibit991.htm EX-99.1 125967
3 miratilogopurplev2a04.jpg GRAPHIC 17052
  Complete submission text file 0001628280-19-002282.txt   186392
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 19643774
SIC: 2834 Pharmaceutical Preparations